Allergan Loses Patent Fight in Federal Court

A U.S. District Court ruled patents for one of Allergan’s best-selling drugs are invalid, potentially opening the door for generic competition.

from WSJ.com: US Business http://ift.tt/2zeVJyD
via IFTTT